BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Seattle Genetics

About Seattle Genetics

Seattle Genetics is a biotechnology company focused on developing monoclonal antibody (mAb)-based therapeutics for cancer and immunologic diseases.

 

CLINICAL TRIAL DATA

 

PIPELINE

SGN-30 is a genetically engineered antibody targeting the CD30 antigen, which is expressed on many types of hematologic malignancies such as Hodgkin's disease and some types of non-Hodgkin's lymphoma.

SGN-15 is an antibody-drug conjugate (ADC) composed of a genetically engineered antibody targeted to an antigen that is conjugated to doxorubicin.A phase II clinical trial has been completed using SGN-15 for the treatment of non-small cell lung cancer in combination with Taxotere.

SGN-40 is a humanized antibody targeted to the CD40 antigen -- target sites are hematologic malignancies such as multiple myeloma and non-Hodgkin's lymphoma.

 

Home Page

Key Statistics for Seattle Genetics

Basic Chart for Seattle Genetics

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com